Alliancebernstein L.P. Has $17.30 Million Stock Holdings in HealthEquity, Inc. (NASDAQ:HQY)

Alliancebernstein L.P. decreased its position in HealthEquity, Inc. (NASDAQ:HQY) by 2.3% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 180,346 shares of the company’s stock after selling 4,290 shares during the period. Alliancebernstein L.P. owned 0.21% of HealthEquity worth $17,304,000 at the end of the most recent quarter.

A number of other institutional investors have also recently bought and sold shares of the business. Arcadia Investment Management Corp MI acquired a new stake in shares of HealthEquity in the 4th quarter valued at approximately $26,000. Smartleaf Asset Management LLC increased its position in HealthEquity by 34.3% during the 4th quarter. Smartleaf Asset Management LLC now owns 384 shares of the company’s stock worth $37,000 after buying an additional 98 shares during the period. Proficio Capital Partners LLC acquired a new stake in HealthEquity in the 4th quarter worth about $39,000. UMB Bank n.a. raised its position in shares of HealthEquity by 65.6% in the fourth quarter. UMB Bank n.a. now owns 414 shares of the company’s stock valued at $40,000 after buying an additional 164 shares in the last quarter. Finally, Skandinaviska Enskilda Banken AB publ grew its stake in HealthEquity by 1,934.8% during the fourth quarter. Skandinaviska Enskilda Banken AB publ now owns 468 shares of the company’s stock worth $45,000 after buying an additional 445 shares in the last quarter. Institutional investors and hedge funds own 99.55% of the company’s stock.

HealthEquity Trading Down 4.5 %

HQY opened at $76.77 on Wednesday. The company has a debt-to-equity ratio of 0.51, a current ratio of 3.20 and a quick ratio of 3.20. HealthEquity, Inc. has a fifty-two week low of $65.01 and a fifty-two week high of $115.59. The company’s 50 day moving average price is $99.92 and its two-hundred day moving average price is $96.32. The firm has a market capitalization of $6.64 billion, a price-to-earnings ratio of 70.43, a PEG ratio of 1.60 and a beta of 0.49.

Wall Street Analysts Forecast Growth

A number of brokerages have recently weighed in on HQY. Royal Bank of Canada upped their price target on shares of HealthEquity from $100.00 to $105.00 and gave the stock an “outperform” rating in a report on Tuesday, December 10th. KeyCorp reduced their target price on HealthEquity from $120.00 to $110.00 and set an “overweight” rating on the stock in a report on Monday, March 24th. Barrington Research restated an “outperform” rating and set a $112.00 price objective on shares of HealthEquity in a research report on Friday, March 14th. Raymond James upgraded HealthEquity from an “outperform” rating to a “strong-buy” rating and decreased their target price for the company from $120.00 to $115.00 in a research report on Tuesday, March 25th. Finally, The Goldman Sachs Group reduced their price target on shares of HealthEquity from $107.00 to $94.00 and set a “neutral” rating on the stock in a research note on Thursday, March 27th. One research analyst has rated the stock with a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Buy” and an average price target of $112.58.

Insider Buying and Selling

In related news, Director Robert W. Selander sold 5,750 shares of HealthEquity stock in a transaction that occurred on Monday, February 10th. The stock was sold at an average price of $111.29, for a total value of $639,917.50. Following the transaction, the director now directly owns 78,219 shares of the company’s stock, valued at $8,704,992.51. The trade was a 6.85 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Michael Henry Fiore sold 8,881 shares of the stock in a transaction that occurred on Friday, April 4th. The shares were sold at an average price of $78.26, for a total transaction of $695,027.06. Following the sale, the executive vice president now directly owns 56,655 shares of the company’s stock, valued at $4,433,820.30. This represents a 13.55 % decrease in their position. The disclosure for this sale can be found here. 2.20% of the stock is currently owned by insiders.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.